<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24904" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Autosomal Dominant Tubulointerstitial Kidney Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shamam</surname>
            <given-names>Younus M.</given-names>
          </name>
          <aff>University of Mosul, College of Medicine , Mosul Iraq</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Younus Shamam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24904.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited kidney disorders. It is usually characterized by progressive renal insufficiency, tubulointerstitial nephropathy, and bland urinary sediment. This condition is inherited in an autosomal dominant manner. It must be promptly diagnosed and treated to avoid the high morbidity and mortality associated with this condition. This activity describes the etiology, evaluation, and treatment of autosomal dominant tubulointerstitial kidney disease and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of autosomal dominant tubulointerstitial kidney disease.</p></list-item><list-item><p>Describe the appropriate evaluation of autosomal dominant tubulointerstitial kidney disease.</p></list-item><list-item><p>Outline the management options available for autosomal dominant tubulointerstitial kidney disease.</p></list-item><list-item><p>Review interprofessional team strategies for improving care coordination and communication to advance autosomal dominant tubulointerstitial kidney disease and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24904&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24904">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24904.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited kidney disorders. It is usually characterized by&#x000a0;progressive renal insufficiency, tubulointerstitial nephropathy, and bland urinary sediment. Multiple names have been&#x000a0;suggested for this group of disorders, including &#x02018;familial juvenile hyperuricemic nephropathy (FJHN),&#x02019; &#x02018;medullary cystic kidney disease (MCKD) type 2&#x02019;, &#x02018;uromodulin-associated kidney disease (UAKD),&#x02019; UMOD-related diseases, and &#x02018;MCKD type 1&#x02019;. However, the variety of these names, and the idea that cysts are not pathognomonic, generates confusion. Kidney Disease: Improving Global Outcomes (KDIGO)&#x000a0;suggests the adoption of new terminology for these diseases using&#x000a0;a single name&#x000a0;&#x02018;autosomal dominant tubulointerstitial kidney disease&#x02019; (ADTKD)&#x000a0;adjoining a gene-based subclassification and diagnostic criteria. These recommendations are anticipated to bring about homogeneity in the characterization of this monogenic group of diseases.</p>
        <p>This condition is inherited in an autosomal dominant manner. To date, many different gene mutations that cause ADTKD have been detected, such as uromodulin (UMOD), renin (REN),&#x000a0;mucin-1 (MUC1), hepatocyte nuclear factor 1&#x003b2; (HNF1B), and SEC. 61A1&#x000a0;mutations.<xref ref-type="bibr" rid="article-24904.r1">[1]</xref><xref ref-type="bibr" rid="article-24904.r2">[2]</xref>&#x000a0;These genes encode different proteins, which are imperative for normal renal function. The clinical scenario is varied and non-specific, and it is dependent on the type of gene mutation. The clinical manifestation of diseases associated with mutations in MUC1, UMOD, and REN appears to be limited to the kidney; however, HNF1B mutations&#x000a0;cause variable extrarenal manifestations.<xref ref-type="bibr" rid="article-24904.r3">[3]</xref></p>
        <p>It is difficult to diagnose this condition because it is a rare and&#x000a0;recently identified disorder that is not well known to most primary health care providers and nephrologists.<xref ref-type="bibr" rid="article-24904.r4">[4]</xref></p>
      </sec>
      <sec id="article-24904.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Autosomal dominant tubulointerstitial kidney disease is a rare renal disorder caused by variable mutations in different genes. As discussed previously, at least five different gene mutations have been observed to result in this group of disorders.&#x000a0;An autosomal dominant inheritance pattern inherits this disorder.&#x000a0;MUC1&#x000a0;gene encodes a mucin-1 protein,&#x000a0;UMOD&#x000a0;gene encodes uromodulin protein (previously known as Tamm-Horsfall protein),&#x000a0;HNF1B&#x000a0;gene encodes hepatocyte nuclear factor 1 beta,&#x000a0;REN&#x000a0;gene encodes renin, and&#x000a0;SEC61A1&#x000a0;gene encodes translocon subunit SEC61A.<xref ref-type="bibr" rid="article-24904.r5">[5]</xref>&#x000a0;The details of the pathogenesis underlying these genetic mutations will be discussed in the pathophysiology section of this article.</p>
      </sec>
      <sec id="article-24904.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Since autosomal dominant tubulointerstitial kidney disease is a rare and recently identified disorder, the exact prevalence has not been determined, neither in the United States of America nor worldwide.<xref ref-type="bibr" rid="article-24904.r5">[5]</xref>&#x000a0;There is no difference in the incidence rate between males and females because this condition is inherited in an autosomal dominant manner. The child, either sex, has a&#x000a0;50% chance of inheriting the mutated gene.&#x000a0;The mean age of end-stage&#x000a0;renal disease (ESRD) is 45 years old, but the range is variable, starting from 17 years old up to 75 years old.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref>&#x000a0;No geographic or sex differences are reported.</p>
        <p>ADTKD-UMOD may present&#x000a0;in adolescence with gout; hyperuricemia&#x000a0;is highly prevalent. Chronic kidney disease (CKD) is often diagnosed in late adolescence or early adulthood. ADTKD-REN&#x000a0;could present with&#x000a0;hyperkalemia, anemia, and CKD as early as infancy. ADTKD-MUC1&#x000a0;patients generally develop CKD in their early twenties. ADTKD-HNF1B&#x000a0;could present with genitourinary abnormalities in childhood, gout or diabetes in the teenage years, and CKD in the third decade of life. Extrarenal abnormalities are also possible. All subtypes usually lead to progressive ESRD, occurring typically&#x000a0;between 25 and 70 years of age, and those with gout experience its onset between the age range of 3 and 51 years.<xref ref-type="bibr" rid="article-24904.r7">[7]</xref><xref ref-type="bibr" rid="article-24904.r8">[8]</xref> For instance, a study in Ireland reported that&#x000a0;ADTKD was the underlying cause of ESRD in at least 0.54% of patients.<xref ref-type="bibr" rid="article-24904.r5">[5]</xref></p>
        <p>ADTKD is believed to be one of the commonest monogenic forms of renal disease, and overall it accounts for around 5% of all monogenic causes of CKD.<xref ref-type="bibr" rid="article-24904.r9">[9]</xref>&#x000a0;The prevalence of the&#x000a0;various types of ADTKD has not been widely studied; however, ADTKD-UMOD and ADTKD-MUC1 are&#x000a0;perhaps more frequently encountered than ADTKD&#x000a0;due to mutations in HNF1B or REN. In many studies, ADTKD-UMOD was the most common genetic kidney disease after ADPKD, with a population prevalence of 9 per million.<xref ref-type="bibr" rid="article-24904.r10">[10]</xref></p>
      </sec>
      <sec id="article-24904.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In autosomal dominant tubulointerstitial kidney disease-MUC1, the&#x000a0;MUC1&#x000a0;gene is located on chromosome 1q21. It is thought that most&#x000a0;MUC1&#x000a0;mutations are caused by cytosine duplication within a seven-cytosine stretch in the variable-number tandem repeats (VNTR) region that usually produces a frameshift mutation. This mutated gene produces an abnormal protein known as the MUC1 frameshift protein (MUC1fs). Accumulating this abnormal protein (MUC1fs) in the renal tubular epithelial cells may be considered an important pathogenic factor in the pathophysiology of ADTKD-MUC1; in addition, positive staining of (MUC1fs) in the&#x000a0;urinary exfoliated cells and renal tubular epithelial cells could help to diagnose this condition.<xref ref-type="bibr" rid="article-24904.r1">[1]</xref></p>
        <p>In ADTKD-UMOD, endoplasmic reticulum stress may occur due to the retention of the mutant uromodulin (mUMOD) protein inside the endoplasmic reticulum (ER) of tubular epithelial cells in the thick ascending limb of the renal tubules. This will lead to tubular cell death,&#x000a0;decreased cellular release, urinary excretion of the wild-type protein, and chronic kidney disease.<xref ref-type="bibr" rid="article-24904.r11">[11]</xref><xref ref-type="bibr" rid="article-24904.r12">[12]</xref>&#x000a0;Additionally, the defective biogenesis and intracellular uromodulin transport affect the Na-K-2Cl cotransporter&#x000a0;resulting in defective urinary concentration and mild volume depletion, secondarily increasing proximal reabsorption of uric acid, leading to&#x000a0;hyperuricemia.<xref ref-type="bibr" rid="article-24904.r13">[13]</xref><xref ref-type="bibr" rid="article-24904.r14">[14]</xref> About two-thirds of the mutations that cause ADTKD-UMOD&#x000a0;(mUMOD) involve cysteine residues, and no mutations are reported resulting in&#x000a0;loss of transcription or truncation. All these findings imply the important role of the&#x000a0;mutant uromodulin (mUMOD) protein in the pathophysiology of ADTKD-UMOD.<xref ref-type="bibr" rid="article-24904.r15">[15]</xref></p>
        <p>In autosomal dominant tubulointerstitial kidney disease-SEC61A1,&#x000a0;this condition is associated with&#x000a0;missense mutations in&#x000a0;SEC61A1. It is responsible for encoding the alpha subunit of&#x000a0;endoplasmatic reticular membrane translocon SEC61. Many studies confirmed that the normal function of the SEC61 complex and its translocon is essential for normal kidney development.<xref ref-type="bibr" rid="article-24904.r16">[16]</xref></p>
        <p>In autosomal dominant tubulointerstitial kidney disease-REN,&#x000a0;the disease is mainly caused by non-truncating mutations in the first exon of the REN gene that affect the protein leader peptide residues. The type of the mutation is either&#x000a0;missense changes like (L16R, W10R, W17R, and C20R) or&#x000a0;an in-frame deletion (L16del). Another study identified a new novel renin mutation in exon 10 of the REN gene. These mutations can lead to endoplasmic reticulum stress and unfolded protein response activation, leading to improper renal development.<xref ref-type="bibr" rid="article-24904.r17">[17]</xref></p>
        <p>In autosomal dominant tubulointerstitial kidney disease-HNF1B,&#x000a0;the&#x000a0;HNF1B&#x000a0;gene has an essential role in early embryonic development. It is also known as transcription factor-2 (TCF2). This gene is located on chromosome 17q12, which codes for protein hepatocyte nuclear factor 1 homeobox B. Since&#x000a0;HNF1B&#x000a0;is expressed in the body's variable tissues like the kidney, liver, pancreas, and genitourinary tract, this may explain the variable clinical presentations of the&#x000a0;HNF1B-related disorders. It was&#x000a0;found that loss of&#x000a0;HNF1b&#x000a0;could induce epithelial-mesenchymal transition. This transition will ultimately lead to kidney fibrosis by&#x000a0;up-regulation of the expression of transforming growth factor&#x02212;&#x003b2; ligands in renal&#x000a0;epithelial cells.<xref ref-type="bibr" rid="article-24904.r18">[18]</xref></p>
      </sec>
      <sec id="article-24904.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histology of autosomal dominant tubulointerstitial kidney disease shows interstitial fibrosis with normal glomeruli and tubular atrophy. Lamellation and thickening of tubular basement membranes are frequent findings.<xref ref-type="bibr" rid="article-24904.r3">[3]</xref><xref ref-type="bibr" rid="article-24904.r19">[19]</xref><xref ref-type="bibr" rid="article-24904.r7">[7]</xref><xref ref-type="bibr" rid="article-24904.r20">[20]</xref>&#x000a0;Tubular dilatation could be seen, and tubular microcysts have been observed. Immunofluorescence for immunoglobulins and complement is negative. Electron microscopy provides little or no additional information; however,&#x000a0;it may reveal the accumulation of mUMOD in the ER&#x000a0;of thick ascending loop cells.<xref ref-type="bibr" rid="article-24904.r21">[21]</xref>&#x000a0;The following is the list of changes that have been reported in association with various types of ADTKD:</p>
        <list list-type="bullet">
          <list-item>
            <p>Interstitial fibrosis</p>
          </list-item>
          <list-item>
            <p>Tubular atrophy</p>
          </list-item>
          <list-item>
            <p>Thickening and lamellation of tubular basement membranes</p>
          </list-item>
          <list-item>
            <p>Possibly tubular dilatation (microcysts)</p>
          </list-item>
          <list-item>
            <p>Negative immunofluorescence for complement and immunoglobulins</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24904.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Autosomal dominant tubulointerstitial kidney disease is a group of inherited kidney disorders caused by different gene mutations that share the same histological findings. Occasionally, nephronophthisis may&#x000a0;appear in young&#x000a0;individuals with features suggestive of ADTKD; however, autosomal recessive inheritance differentiates it from ADTKD3.<xref ref-type="bibr" rid="article-24904.r22">[22]</xref>&#x000a0;The rate of decline of the estimated glomerular filtration rate is&#x000a0;exceedingly variable in ADTKD-MUC1, ADTKD-UMOD, and ADTKD-HNF1B.<xref ref-type="bibr" rid="article-24904.r19">[19]</xref><xref ref-type="bibr" rid="article-24904.r7">[7]</xref>&#x000a0;The urinary sediment is&#x000a0;generally normal, but microhematuria can occasionally be seen. Proteinuria is either mild or completely absent. Glomerular involvement has been rarely found, such as&#x000a0;in glomerulocystic disease and secondary focal segmental glomerulosclerosis.<xref ref-type="bibr" rid="article-24904.r23">[23]</xref> The initially normal kidney size&#x000a0;starts to decline with advancing disease. Patients&#x000a0;generally have no history of hypertension preceding impaired&#x000a0;renal function. With progression, blood pressure could increase, but typically only modestly.</p>
        <p>The clinical manifestations are widely variable and gene-dependent. The following is a discussion that encompasses the most likely observed clinical features with each gene mutation:</p>
        <p>ADTKD-MUC1 was previously called medullary cystic kidney disease type 1. This disease is characterized by progressive tubulointerstitial fibrosis that ultimately leads to ESRD. ESRD typically starts in adulthood, but it may occur at any age, from 20 years old to 70 years old. There are no other systemic manifestations. Since this disease is transmitted in an autosomal dominant manner, a family history of chronic renal insufficiency is an important key point to figuring out this disease.<xref ref-type="bibr" rid="article-24904.r24">[24]</xref></p>
        <p>ADTKD-UMOD&#x000a0;was&#x000a0;known historically as familial juvenile hyperuricemic nephropathy type 1 (FJHN1),&#x000a0;uromodulin-associated kidney disease (UMOD-associated kidney disease), and medullary cystic kidney disease type 2 (MCKD2). The clinical manifestation is slowly progressive chronic kidney disease, usually noticed in the teen years, and progression to&#x000a0;ESRD between the fourth and seventh decades of life. Other important clinical features are gout and hyperuricemia, resulting from inappropriately decreased fractional urate excretion that usually occurs as early as the teenage years.<xref ref-type="bibr" rid="article-24904.r25">[25]</xref></p>
        <p>ADTKD-REN was&#x000a0;known&#x000a0;previously as familial juvenile hyperuricemic nephropathy type 2 (FJHN2).&#x000a0;This disease&#x000a0;is&#x000a0;characterized by hypo-proliferative anemia with a low hemoglobin concentration in the first decade of life. The clinical symptoms of CKD and hyperuricemia start in childhood or adolescence. This condition is also characterized by bland urinary sediment,&#x000a0;mildly elevated serum potassium concentration,&#x000a0;slightly decreased blood pressure,&#x000a0;polyuria, and low plasma renin activity.&#x000a0;Patients usually progress to ESRD in their fourth to sixth decade of life.<xref ref-type="bibr" rid="article-24904.r17">[17]</xref></p>
        <p>ADTKD-SEC61A1&#x000a0;is a newly discovered disease caused by a mutation in&#x000a0;SEC61A1. Since it is a new disease, the whole clinical picture is not conspicuous. To date, very few families have been identified with this disorder. In one family, dysplastic kidneys, anemia, and intrauterine growth retardation were present. In another family, anemia,&#x000a0;neutropenia with abscess formation, and chronic kidney disease were documented.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
        <p>A mutation in the TCF2 gene causes ADTKD-HNF1B. The kidney and the pancreas express the homeodomain-containing transcription factors hepatocyte nuclear factor 1 alpha and 1 beta.&#x000a0;Research has identified that mutations in this gene may cause the maturity-onset diabetes of youth (MODY), but further studies explicate that mutations in this gene may also lead to renal manifestations. The&#x000a0;varied clinical manifestations and the fact that these clinical manifestations are not&#x000a0;present consistently in all affected family members made diagnosing this condition difficult. The non-renal manifestations may include maturity-onset diabetes mellitus of the young, abnormal liver function tests of unclear etiology, genito-urinary tract malformations, and hyperuricemia with gout. In adolescence, hypomagnesemia may occur in some individuals. The renal manifestations are common in adulthood and often involve&#x000a0;numerous renal cysts, congenital solitary kidney, congenital anomalies of the kidney and urinary tract system, renal dysplasia, and hypoplastic kidneys.<xref ref-type="bibr" rid="article-24904.r26">[26]</xref><xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
      </sec>
      <sec id="article-24904.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Since autosomal dominant tubulointerstitial kidney disease is a rare condition and difficult to predict, it is prudent for health care providers to&#x000a0;consider&#x000a0;this disease, especially&#x000a0;if the patient has signs and symptoms of renal failure at a young age with a family history of end-stage renal disease. However, even with limited knowledge, nephrologists can obtain the diagnosis and improve patient care with the help of the following criteria:</p>
        <p>
<bold>Criteria for Suspecting a Diagnosis of ADTKD</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Family history is compatible with the autosomal dominant pattern of inheritance of CKD&#x000a0;in line with&#x000a0;clinical characteristics (as mentioned above).</p>
          </list-item>
          <list-item>
            <p>In the absence of a family history of CKD in line with clinical characteristics, demonstration of relevant&#x000a0;histology on&#x000a0;renal biopsy or extrarenal features&#x000a0;compatible with HNF1B mutation, or history of early-onset hyperuricemia&#x000a0;with or without gout.</p>
          </list-item>
        </list>
        <p>
<bold>Criteria for Establishing the Diagnosis of ADTKD</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Family history is compatible with the autosomal dominant pattern of inheritance of CKD&#x000a0;in line with&#x000a0;clinical characteristics (as mentioned above) and&#x000a0;relevant histology in at least one affected relative. (Of note, it is not possible to establish a definitive diagnosis by kidney biopsy alone)or</p>
          </list-item>
          <list-item>
            <p>Demonstration of mutation in at least one of the four genes in&#x000a0;the patient or at least one family member</p>
          </list-item>
        </list>
        <p>The variable rate of decline in renal function with the mean age of end-stage renal disease is approximately 45 years, but the range is 17 years up to 75 years.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
        <p>In&#x000a0;ADTKD-<italic toggle="yes">MUC1,&#x000a0;</italic>genetic diagnosis is not straightforward.&#x000a0;It is essential to know that testing for the&#x000a0;<italic toggle="yes">MUC1 </italic>gene&#x000a0;mutation is not a direct mutational analysis, and this test is not performed at commercial clinical laboratories at this time. A recent study was conducted to detect&#x000a0;MUC1fs protein by&#x000a0;immunostaining the MUC1fs protein on the epithelial tissues and the urinary cell smears in individuals with ADTKD-<italic toggle="yes">MUC1,</italic>&#x000a0;and the result is promising. Still, it is not readily available at the clinical lab yet.<xref ref-type="bibr" rid="article-24904.r27">[27]</xref></p>
        <p>In&#x000a0;ADTKD-<italic toggle="yes">UMOD,</italic>&#x000a0;the diagnosis may be made based on the appropriate and relevant clinical scenario and the knowledge that another family member has been identified with a&#x000a0;<italic toggle="yes">UMOD</italic>&#x000a0;mutation on genetic testing. However,&#x000a0;uromodulin genetic analysis is readily available at commercial clinical laboratories.<xref ref-type="bibr" rid="article-24904.r25">[25]</xref></p>
        <p>In&#x000a0;ADTKD-<italic toggle="yes">REN, </italic>genetic analysis of the&#x000a0;<italic toggle="yes">REN</italic>&#x000a0;gene should always be used to make the diagnosis. When the renin and aldosterone are stimulated, the levels are in the low normal range in most patients, making this type of measurement inadequate for making the diagnosis.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
        <p>In&#x000a0;ADTKD-<italic toggle="yes">HNF1B, </italic>this condition's&#x000a0;clinical scenario is widely variable, with different renal and extrarenal clinical manifestations. The&#x000a0;cost-effective NGS-based strategies allow rapid and simultaneous sequencing of several genes, including&#x000a0;<italic toggle="yes">HNF1B.</italic><xref ref-type="bibr" rid="article-24904.r18">[18]</xref></p>
        <p>In ADTKD-<italic toggle="yes">SEC61A1,&#x000a0;</italic>very few families have been diagnosed with this condition. Currently, the diagnostic criteria are still under development.</p>
      </sec>
      <sec id="article-24904.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of&#x000a0;autosomal dominant tubulointerstitial kidney disease mainly focuses on managing the symptoms associated with each type of disease and slowing down the progression to end-stage renal disease.&#x000a0;It seems reasonable that potentially affected family members be well managed for other risk factors known to worsen or cause CKD, such as arterial hypertension, diabetes, smoking, and obesity, and annual kidney function testing&#x000a0;is necessary. There are few treatment options for&#x000a0;children&#x000a0;at risk for UMOD- or MUC1-associated&#x000a0;diseases. On the contrary,&#x000a0;minors with HNF1B- and REN-associated diseases are likely to&#x000a0;improve from early treatment. Affected individuals should typically be treated according to established CKD guidance.<xref ref-type="bibr" rid="article-24904.r28">[28]</xref>&#x000a0;The followings are the most important management options for each sub-type of the disease:</p>
        <p>Regarding ADTKD-UMOD,&#x000a0;allopurinol or febuxostat are the best treatment options for gout and hyperuricemia. Patients should be encouraged to take one of these medications as soon as gout develops to prevent further gout attacks and gouty tophi. Although starting allopurinol early in life may prevent gout from developing later, the risks and benefits should be discussed thoroughly with the patient or the family if the patient is minor because allopurinol has some important side effects and severe allergic reactions.<xref ref-type="bibr" rid="article-24904.r29">[29]</xref>&#x000a0;It is also essential to inform all women of child-bearing age that this medication may have some teratogenic effects and should be stopped before the pregnancy.<xref ref-type="bibr" rid="article-24904.r30">[30]</xref>&#x000a0;As kidney disease progression is typically slow, and the&#x000a0;UMOD&#x000a0;mutations affect only the kidneys, these patients are excellent renal transplantation candidates.</p>
        <p>Regarding ADTKD-MUC1, there is no specific therapy at present. Optimal therapy to manage chronic kidney disease, such as controlling blood pressure and secondary chronic&#x000a0;kidney disease changes, are the only available treatments for this condition.&#x000a0;As progression to end-stage&#x000a0;renal disease is at a slow rate, and the fact that this condition affects only the kidney,&#x000a0;these patients are excellent candidates for renal transplantation.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
        <p>For ADTKD-REN,&#x000a0;there are several treatment options currently available. As these patients are in&#x000a0;mild hypovolemia with a low renin state,&#x000a0;it is essential to avoid the low sodium diet, commonly recommended for chronic kidney disease.&#x000a0;These patients are prone to develop acute kidney injury on a low sodium diet due to worsening hypotension. Hyperkalemia and mild hypotension could be treated by fludrocortisone or a higher sodium content diet.&#x000a0;Fludrocortisone may correct hyperkalemia and hypotension and improve hyperuricemia but does not ameliorate hemoglobin levels.&#x000a0;Fludrocortisone may slow chronic kidney disease progression by lowering renin production (both the normal and the mutated renin).<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
        <p>For ADTKD-HNF1B,&#x000a0;there is no specific therapy for this disease. The treatment is mainly supportive of chronic kidney disease. Allopurinol or febuxostat should be considered for patients with early-onset gout to prevent&#x000a0;tophus development and urate accumulation.&#x000a0;Screening for abnormal liver function tests, hyperglycemia, hypomagnesemia, and hyperuricemia is an essential part of the management to prevent further complications. Renal ultrasound should be performed to evaluate renal morphologic abnormalities.<xref ref-type="bibr" rid="article-24904.r31">[31]</xref><xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
        <p>Regarding ADTKD-SEC61A1,&#x000a0;there is no specific therapy to treat the underlying cause, but managing the associated congenital anemia and preventing opportunistic infection should be carried out for a better prognosis.</p>
        <p>It is important to know that patients with ADTKD are excellent candidates for kidney transplantation, particularly if there are no extra-renal manifestations.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
      </sec>
      <sec id="article-24904.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Autosomal dominant tubulointerstitial kidney disease is a congenital renal anomaly that ultimately leads to end-stage&#x000a0;renal disease. This condition is inherited in an autosomal dominant manner. It is essential to exclude other congenital renal diseases before making the diagnosis.<xref ref-type="bibr" rid="article-24904.r24">[24]</xref><xref ref-type="bibr" rid="article-24904.r25">[25]</xref> The following consists of the most likely differential diagnosis of this condition:</p>
        <list list-type="bullet">
          <list-item>
            <p>Early-onset autosomal dominant polycystic kidney disease</p>
          </list-item>
          <list-item>
            <p>Autosomal recessive&#x000a0;polycystic kidney disease</p>
          </list-item>
          <list-item>
            <p>Urinary tract obstruction</p>
          </list-item>
          <list-item>
            <p>Renal dysplasia</p>
          </list-item>
          <list-item>
            <p>Gout</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24904.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although autosomal dominant tubulointerstitial kidney disease is considered benign,&#x000a0;most cases will ultimately develop end-stage&#x000a0;renal disease. To improve the prognosis, the treatment should focus on slowing the progression to ESRD. The mean age at which the&#x000a0;ESRD develops&#x000a0;is variable, and it depends on the form of the disease; it could be at a younger age, as in the teens or later in adulthood.&#x000a0;Lifelong treatment could control the symptoms associated with chronic kidney disease, but it will not treat the underlying cause. It was documented that renal transplantation may have an excellent prognosis, especially if the kidney is the only organ affected.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref><xref ref-type="bibr" rid="article-24904.r29">[29]</xref></p>
      </sec>
      <sec id="article-24904.s12" sec-type="Complications">
        <title>Complications</title>
        <p>ESRD&#x000a0;is the most critical complication associated with autosomal dominant tubulointerstitial kidney disease.&#x000a0;ESRD leads to variable health issues that should be addressed thoroughly and appropriately treated.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref><xref ref-type="bibr" rid="article-24904.r29">[29]</xref>&#x000a0;The followings encompass the most likely complications associated with ESRD:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anemia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Osteoporosis and fracture</p>
          </list-item>
          <list-item>
            <p>Platelet dysfunction with easy bruising</p>
          </list-item>
          <list-item>
            <p>Congestive heart failure</p>
          </list-item>
          <list-item>
            <p>Pericarditis</p>
          </list-item>
          <list-item>
            <p>Menstrual problems and infertility</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Peripheral neuropathy</p>
          </list-item>
          <list-item>
            <p>Hyperkalemia and cardiac arrest</p>
          </list-item>
        </list>
        <p>In addition to the complications associated with ESRD, each form of this disease has certain complications that should be addressed as well to improve the patient quality of life as the following:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>ADTKD-UMOD&#x000a0;is associated with hyperuricemia and gout</p>
          </list-item>
          <list-item>
            <p>ADTKD-REN&#x000a0;is associated with hypo-proliferative anemia, hyperuricemia, mild hypotension, mild hyperkalemia</p>
          </list-item>
          <list-item>
            <p>ADTKD-HNF1B&#x000a0;is associated with&#x000a0;maturity-onset diabetes of the young, abnormal liver function test of unclear etiology, genito-urinary tract malformations, hyperuricemia with gout, and hypomagnesemia</p>
          </list-item>
          <list-item>
            <p>ADTKD-SEC61A1&#x000a0;is associated with anemia and neutropenia with abscess formation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24904.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The management of autosomal dominant tubulointerstitial kidney disease and its complications require an interprofessional team consisting of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nephrologist</p>
          </list-item>
          <list-item>
            <p>Hepatologist</p>
          </list-item>
          <list-item>
            <p>Cardiologist</p>
          </list-item>
          <list-item>
            <p>Hematologist</p>
          </list-item>
          <list-item>
            <p>Nurse practitioners</p>
          </list-item>
          <list-item>
            <p>Pharmacists</p>
          </list-item>
          <list-item>
            <p>Hemodialysis technicians</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24904.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with autosomal dominant tubulointerstitial kidney disease should be informed about this disease's congenital nature. Health professionals should clarify that there are no available medications to treat the underlying cause. The management plan should focus on preventive measures to slow the progression of the disease to&#x000a0;ESRD and relieve the symptoms associated with each form of the disease.</p>
        <p>Health care providers must also advise patients about the importance of medication adherence and compliance. Since this condition is transmitted in an autosomal dominant manner, other family members are likely to be affected even if they are asymptomatic, so screening for genetic mutations in the affected family members is rational.<xref ref-type="bibr" rid="article-24904.r6">[6]</xref></p>
      </sec>
      <sec id="article-24904.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of this condition requires the collaboration of the entire&#x000a0;interprofessional team. The primary healthcare provider should be aware of this condition, especially if the patient presents with a progressive decline in renal function associated with bland urinary sediment. These patients should be referred to a nephrologist to manage renal insufficiency and prepare them for renal transplantation if mandatory. Nurses and pharmacists can also contribute with patient counseling about the condition, and in the case of pharmacists, regarding proper dosing and medication compliance. If it is confirmed that the patient carries the mutated gene, other family members should be screened for that mutation as their probability of being affected is high, and early screening could improve the prognosis and outcomes, so a genetics specialist may also need to be included in case management.</p>
        <p>All interprofessional team members are responsible for documenting their observations and interventions in the patient's medical record, so all providers operate from the same data. If they notice any issues of concern, then open communication with appropriate team members is crucial to initiating proper therapeutic interventions so the patient will receive optimal care. This interprofessional model that includes clinicians, nurses, pharmacists, and other specialists will lead to the best patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-24904.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24904&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24904">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/autosomal-dominant-tubulointerstitial-kidney-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24904">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24904/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24904">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24904.s17">
        <title>References</title>
        <ref id="article-24904.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>GQ</given-names>
              </name>
              <name>
                <surname>Rui</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>ZR</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>SMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family.</article-title>
            <source>Sci Rep</source>
            <year>2020</year>
            <month>May</month>
            <day>25</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>8616</fpage>
            <pub-id pub-id-type="pmid">32451462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gnirke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Bare&#x00161;ov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pochet</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Blumenstiel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aird</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Cabili</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Gat-Viks</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kelliher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Daza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>DeFelice</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>H&#x0016f;lkov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sovov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vylet'al</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Antignac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guttman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Handsaker</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Perrin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Steelman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sigurdsson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scheinman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sougnez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cibulskis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parkin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rossin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zody</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Alper</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Lindblad-Toh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Regev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nusbaum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lander</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.</article-title>
            <source>Nat Genet</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-303</page-range>
            <pub-id pub-id-type="pmid">23396133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faguer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Decramer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chassaing</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bellann&#x000e9;-Chantelot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calvas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Beaufils</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bessenay</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lengel&#x000e9;</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Dahan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ronco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Chauveau</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood.</article-title>
            <source>Kidney Int</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>80</volume>
            <issue>7</issue>
            <fpage>768</fpage>
            <page-range>768-76</page-range>
            <pub-id pub-id-type="pmid">21775974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Olinger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eckardt</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Autosomal dominant tubulointerstitial kidney disease.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2019</year>
            <month>Sep</month>
            <day>05</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <pub-id pub-id-type="pmid">31488840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cormican</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Connaughton</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fennelly</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>O'Kelly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Cavalleri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Foley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dorman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland.</article-title>
            <source>Ren Fail</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>832</fpage>
            <page-range>832-841</page-range>
            <pub-id pub-id-type="pmid">31509055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Autosomal Dominant Tubulointerstitial Kidney Disease.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-93</page-range>
            <pub-id pub-id-type="pmid">28284384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boll&#x000e9;e</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dahan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Flamant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morini&#x000e8;re</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pawtowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heidet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lacombe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pirson</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Antignac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Knebelmann</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>10</issue>
            <fpage>2429</fpage>
            <page-range>2429-38</page-range>
            <pub-id pub-id-type="pmid">21868615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moskowitz</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Piret</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lhotta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kitzler</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Tashman</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Velez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thakker</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Kotanko</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Association between genotype and phenotype in uromodulin-associated kidney disease.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>1349</fpage>
            <page-range>1349-57</page-range>
            <pub-id pub-id-type="pmid">23723338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mabillard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sayer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Olinger</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2023</year>
            <month>Feb</month>
            <day>13</day>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>271</fpage>
            <page-range>271-282</page-range>
            <pub-id pub-id-type="pmid">34519781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gast</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marinaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arenas-Hernandez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seaby</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Pengelly</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Gale</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Connor</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Bunyan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Hoda&#x00148;ov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ennis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Venkat-Raman</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.</article-title>
            <source>BMC Nephrol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>30</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>301</fpage>
            <pub-id pub-id-type="pmid">30376835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernascone</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Janas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ikehata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trudu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Corbelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schaeffer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rastaldi</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure.</article-title>
            <source>Hum Mol Genet</source>
            <year>2010</year>
            <month>Aug</month>
            <day>01</day>
            <volume>19</volume>
            <issue>15</issue>
            <fpage>2998</fpage>
            <page-range>2998-3010</page-range>
            <pub-id pub-id-type="pmid">20472742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernascone</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vavassori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Pentima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santambrogio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lamorte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Amoroso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ghiggeri</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Casari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Polishchuk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Defective intracellular trafficking of uromodulin mutant isoforms.</article-title>
            <source>Traffic</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>7</volume>
            <issue>11</issue>
            <fpage>1567</fpage>
            <page-range>1567-79</page-range>
            <pub-id pub-id-type="pmid">17010121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Amoroso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghiggeri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease.</article-title>
            <source>Kidney Int</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>80</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <page-range>338-47</page-range>
            <pub-id pub-id-type="pmid">21654721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mutig</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kahl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saritas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Godes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Persson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raffi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hille</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dosche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Casta&#x000f1;eda-Bueno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gamba</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner.</article-title>
            <source>J Biol Chem</source>
            <year>2011</year>
            <month>Aug</month>
            <day>26</day>
            <volume>286</volume>
            <issue>34</issue>
            <fpage>30200</fpage>
            <page-range>30200-10</page-range>
            <pub-id pub-id-type="pmid">21737451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vylet'al</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schaeffer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Olinger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoda&#x00148;ov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Robins</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Izzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jorge</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Calado</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lhotta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Steubl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gale</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Gast</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gombos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ainsworth</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Raposeiro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weller</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Cavalleri</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Votruba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vrback&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amoroso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gianchino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Caridi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ghiggeri</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Divers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to <italic>UMOD</italic> Mutations.</article-title>
            <source>Kidney Int Rep</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>9</issue>
            <fpage>1472</fpage>
            <page-range>1472-1485</page-range>
            <pub-id pub-id-type="pmid">32954071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolar</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Golzio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Van Hemelrijk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schepers</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vandeweyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hoischen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huyghe</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Raes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matthys</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sys</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Azou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gubler</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Praet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van Camp</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McFadden</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pediaditakis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>P&#x00159;istoupilov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoda&#x00148;ov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vyle&#x00165;al</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hartmannov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Str&#x000e1;neck&#x000fd;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>H&#x0016f;lkov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bare&#x00161;ov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jedli&#x0010d;kov&#x000e1;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sovov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hn&#x000ed;zda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Spong</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Vande Walle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mortier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brunner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Van Laer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Katsanis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Loeys</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia.</article-title>
            <source>Am J Hum Genet</source>
            <year>2016</year>
            <month>Jul</month>
            <day>07</day>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>174</fpage>
            <page-range>174-87</page-range>
            <pub-id pub-id-type="pmid">27392076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaeffer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Izzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vettori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pasqualetto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cittaro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lazarevic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Caridi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gnutti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jovine</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Aug</month>
            <day>12</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>11601</fpage>
            <pub-id pub-id-type="pmid">31406136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Izzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dordoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Econimo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Delbarba</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grati</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Savoldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alberici</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.</article-title>
            <source>Kidney Int Rep</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>5</volume>
            <issue>12</issue>
            <fpage>2341</fpage>
            <page-range>2341-2350</page-range>
            <pub-id pub-id-type="pmid">33305128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Antignac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Robins</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kelsoe</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hladik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Klemmer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knohl</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Scheinman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Vo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Canaday</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Weller</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hulick</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rahbari-Oskoui</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Tuazon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deltas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Somers</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Megarbane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kimmel</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Sperati</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Orr-Urtreger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ben-Shachar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Waugh</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>McGinn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hodanov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vylet'al</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>527</fpage>
            <page-range>527-35</page-range>
            <pub-id pub-id-type="pmid">24509297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekici</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Hackenbeck</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Morini&#x000e8;re</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pannes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buettner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Uebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Janka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wiesener</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hermann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Grupp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hornberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Isbel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mangos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McGinn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soreth-Rieke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Uder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Antignac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eckardt</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Wiesener</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin.</article-title>
            <source>Kidney Int</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>589</fpage>
            <page-range>589-99</page-range>
            <pub-id pub-id-type="pmid">24670410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasr</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Galgano</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>D'Agati</surname>
                <given-names>VD</given-names>
              </name>
            </person-group>
            <article-title>Uromodulin storage disease.</article-title>
            <source>Kidney Int</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>971</fpage>
            <page-range>971-6</page-range>
            <pub-id pub-id-type="pmid">18004297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoefele</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nayir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Imm</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Hildebrandt</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Pseudodominant inheritance of nephronophthisis caused by a homozygous NPHP1 deletion.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>967</fpage>
            <page-range>967-71</page-range>
            <pub-id pub-id-type="pmid">21258817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lens</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Banet</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Outeda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barrio-Luc&#x000ed;a</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-7</page-range>
            <pub-id pub-id-type="pmid">15983957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Autosomal Dominant Tubulointerstitial Kidney Disease &#x02013; <italic>MUC1</italic></chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2013</year>
            <month>8</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">23946964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Autosomal Dominant Tubulointerstitial Kidney Disease &#x02013; <italic>UMOD</italic></chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2007</year>
            <month>1</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">20301530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verhave</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bech</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Wetzels</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Nijenhuis</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hepatocyte Nuclear Factor 1&#x003b2;-Associated Kidney Disease: More than Renal Cysts and Diabetes.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>345</fpage>
            <page-range>345-53</page-range>
            <pub-id pub-id-type="pmid">26319241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>P&#x00159;istoupilov&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bare&#x00161;ov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>DeFelice</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blumenstiel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Harden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Connaughton</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hartmannov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hoda&#x00148;ov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Str&#x000e1;neck&#x000fd;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vrback&#x000e1;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vyle&#x00165;al</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>&#x0017d;ivn&#x000fd;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Votruba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sovov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>H&#x0016f;lkov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Robins</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Seeman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Viklick&#x000fd;</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rajnochov&#x000e1;-Bloud&#x000ed;&#x0010d;kov&#x000e1;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Papagregoriou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Deltas</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Alper</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Greka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive Immunohistochemical Diagnosis and Novel <italic>MUC1</italic> Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>2418</fpage>
            <page-range>2418-2431</page-range>
            <pub-id pub-id-type="pmid">29967284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>A</given-names>
              </name>
              <collab>Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members</collab>
            </person-group>
            <article-title>Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.</article-title>
            <source>Ann Intern Med</source>
            <year>2013</year>
            <month>Jun</month>
            <day>04</day>
            <volume>158</volume>
            <issue>11</issue>
            <fpage>825</fpage>
            <page-range>825-30</page-range>
            <pub-id pub-id-type="pmid">23732715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eckardt</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Alper</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Antignac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Chauveau</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dahan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Deltas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hosking</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rampoldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wiesener</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Devuyst</surname>
                <given-names>O</given-names>
              </name>
              <collab>Kidney Disease: Improving Global Outcomes</collab>
            </person-group>
            <article-title>Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.</article-title>
            <source>Kidney Int</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>88</volume>
            <issue>4</issue>
            <fpage>676</fpage>
            <page-range>676-83</page-range>
            <pub-id pub-id-type="pmid">25738250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoeltzenbein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stieler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Panse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wacker</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>e66637</fpage>
            <pub-id pub-id-type="pmid">23840514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24904.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faguer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chassaing</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bandin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Prouheze</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garnier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casemayou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schanstra</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Calvas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Decramer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chauveau</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The HNF1B score is a simple tool to select patients for HNF1B gene analysis.</article-title>
            <source>Kidney Int</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>1007</fpage>
            <page-range>1007-15</page-range>
            <pub-id pub-id-type="pmid">24897035</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
